Issued Patents All Time
Showing 1–25 of 34 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428483 | Bispecific tetravalent antibodies and methods of making and using thereof | Zeren Gao, Phil Tan, Brian R. Kovacevich, Blair R. Renshaw, Jeffrey B. Adamo +3 more | 2025-09-30 |
| 12384850 | Guidance and navigation control proteins and method of making and using thereof | Ole Olsen, Dong Xia, David Jellyman, Katrina Bykova, Anne-Marie K. Rousseau +6 more | 2025-08-12 |
| 12285393 | Roles of modulators of intersectin-Cdc42 signaling in Alzheimer's disease | Qun Lu, Yan Chen, Byron Aguilar | 2025-04-29 |
| 12268752 | Non-natural amatoxin-type antibody conjugate | Jie Li, Yongguo YU, Weijia LIU, Shi ZHUO | 2025-04-08 |
| 12029761 | Guidance and Navigation Control proteins and method of making and using thereof | Ole Olsen, Dong Xia, David Jellyman, Katrina Bykova, Anne-Marie K. Rousseau +7 more | 2024-07-09 |
| 11987635 | Anti-4-1BB antibodies and methods of making and using thereof | Ole Olsen, Dong Xia, David Jellyman, Brian R. Kovacevich, Bill Brady +2 more | 2024-05-21 |
| 11980616 | Treating liver disease by selectively eliminating senescent cells | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, James L. Kirkland +1 more | 2024-05-14 |
| 11787863 | Multi-specific antibodies and methods of making and using thereof | Ole Olsen, Dong Xia, David Jellyman, Katrina Bykova, Anne-Marie K. Rousseau +5 more | 2023-10-17 |
| 11649286 | Tri-specific antibodies | Ole Olsen, Dong Xia, David Jellyman, Katrina Bykova, Anne-Marie K. Rousseau +5 more | 2023-05-16 |
| 11560431 | Anti-PD-L1 antibodies and methods of making and using thereof | Brian R. Kovacevich, Dong Xia, Anne Elisabeth Carvalho Jensen, Jonathan K. Fallen, Blair R. Renshaw +3 more | 2023-01-24 |
| 11535667 | Anti-CD3 antibodies and methods of making and using thereof | Ole Olsen, Phil Tan, Dong Xia, David Jellyman, Brian R. Kovacevich +3 more | 2022-12-27 |
| 11517572 | Killing senescent cells and treating senescence-associated conditions using a SRC inhibitor and a flavonoid | James L. Kirkland, Tamar Tchkonia, Allyson K. Palmer, Nathan K. LeBrasseur, Jordan D. Miller | 2022-12-06 |
| 11518815 | Anti-ROR1 antibodies and methods of making and using thereof | Ole Olsen, Phil Tan, Dong Xia, David Jellyman, Brian R. Kovacevich +3 more | 2022-12-06 |
| 11484605 | Cysteine modified antibody-drug conjugate and preparation method thereof | Yixi Wang, Shi ZHUO, Jie Li, Lan Bo Chen, Weili WAN +1 more | 2022-11-01 |
| 11466084 | Anti-PD-1 antibodies and methods of making and using thereof | Brian R. Kovacevich, Dong Xia, Anne Elisabeth Carvalho Jensen, Jonathan K. Fallen, Blair R. Renshaw +3 more | 2022-10-11 |
| 11439608 | Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease | Qun Lu, Byron Aguilar, Yan Chen | 2022-09-13 |
| 11351167 | Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, James L. Kirkland +3 more | 2022-06-07 |
| 10919977 | Bispecific tetravalent antibodies and methods of making and using thereof | Zeren Gao, Phil Tan, Brian R. Kovacevich, Blair R. Renshaw, Jeffrey B. Adamo +3 more | 2021-02-16 |
| 10808005 | Ligand for orphan nuclear receptor Nur77 and uses thereof | Xiaokun Zhang, Xiangzhi Lin, Ying Su, Zhiping Zeng, Mengjie Hu +2 more | 2020-10-20 |
| 10717783 | Bispecific tetravalent antibodies and methods of making and using thereof | Zeren Gao, Phil Tan, Blair R. Renshaw, Brian R. Kovacevich | 2020-07-21 |
| 10517866 | Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor | Remi-Martin Laberge, James L. Kirkland, Tamar Tchkonia, Nathaniel David, Alain P. Vasserot +3 more | 2019-12-31 |
| 10478432 | Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2019-11-19 |
| 10478433 | Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Darren J. Baker +5 more | 2019-11-19 |
| 10413542 | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase | Remi-Martin Laberge, Nathaniel David, Alain P. Vasserot, Darren J. Baker, Bennett G. Childs +3 more | 2019-09-17 |
| 10328073 | Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2019-06-25 |